Pathophysiology of preeclampsia;Physiopathologie de la prééclampsie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 3, 2010, Pages

  Tsatsaris, V ^a   Fournier, T ^b   Winer, N ^c  

^a Maternité Port Royal hôpital Cochin Saint Vincent de Paul ^*  (France)

^b INSERM   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Endoglin; Endothelium disease; Placental failure; Vascular growth factor

Indexed keywords

ARTICLE; BLOOD VESSEL PERMEABILITY; CIRCULATION; ENDOTHELIUM; GLOMERULONEPHRITIS; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PLACENTA DISORDER; PREECLAMPSIA; SECOND TRIMESTER PREGNANCY;

ADULT; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; FEMALE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REGIONAL BLOOD FLOW; UTERUS;

EID: 77952545817     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.02.011     Document Type: Article

References (69)

1. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669-674.
2. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 1991, 12:301-308.
3. Multhaupt H.A., Mazar A., Cines D.B., Warhol M.J., McCrae K.R. Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis. Lab Invest 1994, 71:392-400.
4. Polette M., Nawrocki B., Pintiaux A., Massenat C., Maquoi E., Volders L., et al. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 1994, 71:838-846.
5. Graham C.H., McCrae K.R. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of pre-eclamptic patients. Am J Obstet Gynecol 1996, 175:555-562.
6. Pang Z.J., Xing F.Q. Expression profile of trophoblast invasion-associated genes in the pre-eclamptic placenta. Br J Biomed Sci 2003, 60:97-101.
7. Genbacev O., Zhou Y., Ludlow J.W., Fisher S.J. Regulation of human placental development by oxygen tension. Science 1997, 277:1669-1672.
8. Caniggia L., Grisaru-Gravnosky S., Kuliszewsky M., Post M., Lye S.J. Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in pre-eclamptic pregnancies. J Clin Invest 1999, 103:1641-1650.
9. Rajakumar A., Whitelock K.A., Weissfeld L.A., Daftary A.R., Markovic N., Conrad K.P. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 2001, 64:499-506.
10. Caniggia L., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta (3). J Clin Invest 2000, 105:577-587.
11. Zhou Y., Damsky C.H., Chiu K., Roberts J.M., Fisher S.J. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993, 91:950-960.
12. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 1997, 99:2152-2164.
13. Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003, 69:1-7.
14. Reister F., Frank H.G., Heyl W., Kosanke G., Huppertz B., Schröder W., et al. The distribution of macrophages in spiral arteries of the placental bed in pre-eclampsia differs from that in healthy patients. Placenta 1999, 20:229-233.
15. Reister F., Frank H.G., Kingdom J.C., Heyl W., Kaufmann P., Rath W., et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001, 81:1143-1152.
16. DiFederico E., Genbacev O., Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999, 155:293-301.
17. Huppertz B., Frank H.G., Kaufmann P. Apoptosis along the invasive trophoblastic pathway. Placenta 1998, 19:A35.
18. Lynch D.H., Ramsdell F., Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 1995, 16:569-574.
19. Darmochwal-Kolarz D., Leszczynska-Gorzelak B., Rolinski J., Oleszczuk J. The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe pre-eclampsia. J Reprod Immunol 2001, 49:153-164.
20. Runic R., Lockwood C.J., Ma Y., Dipasquale B., Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 1996, 81:3119-3122.
21. Hsu C.D., Gutierrez L.S., Meaddough E., et al. Expression of FasL by pre-eclamptic placenta. Am J Obstet Gynecol 1999, 180:43S. (1S-II) Supplement.
22. Lim K.H., Zhou Y., Janatpour M., McMaster M., Bass K., Chun S.H., et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997, 151:1809-1818.
23. Goldman-Wohl D.S., Ariel L., Greenfield C., Hochner-Celnikier D., Cross J., Fisher S., et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000, 6:88-95.
24. Colbern G.T., Chiang M.H., Main E.K. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994, 170:1244-1250.
25. Craven C.M., Morgan T., Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 1998, 19:241-252.
26. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
27. Carmeliet P., Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 1999, 237:133-158.
28. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.
29. Clark D.E., Smith S.K., Licence D., Evans A.L., Charnock-Jones D.S. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 1998, 159:459-467.
30. Zhou Y., Bellingard V., Feng K.T., McMaster M., Fisher S.J. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol 2003, 263:114-125.
31. Pavlov N., Hatzi E., Bassaglia Y., Frendo J.L., Brion D.E., Badet J. Angiogenin distribution in human term placenta, and expression by cultured trophoblastic cells. Angiogenesis 2003, 6:317-330.
32. Zygmunt M., Hahn D., Munstedt K., Bischof P., Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta 1998, 19:587-593.
33. Zygmunt M., Herr F., Keller-Schoenwetter S., Kunzi-Rapp K., Münstedt K., Rao C.V., et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 2002, 87:5290-5296.
34. Benirschke K., Kaufmann P. Nonvillous parts and trophoblast invasion. Pathology of the human placenta 2000, Springer-Verlag, New York.
35. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999, 222:222-235.
36. Walsh S.W., Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995, 80:1888-1893.
37. Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992, 167:946-949.
38. Staff A.C., Halvorsen B., Ranheim T., Henriksen T. Elevated level of free 8-iso-prostaglandin F2 alpha in the decidua basalis of women with preeclampsia. Am J Obstet Gynecol 1999, 181:1211-1215.
39. Staff A.C., Ranheim T., Khoury J., Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 1999, 180:587-592.
40. Davidge S.T. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 1998, 16:65-73.
41. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C., McLaughlin M.K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992, 79:897-901.
42. Kharb S., Gulati N., Singh V., Singh G.P. Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 1998, 46:238-240.
43. Kharb S. Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2000, 93:37-39.
44. Many A., Hubel C.A., Fisher S.J., Roberts J.M., Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000, 156:321-331.
45. Hung T.H., Skepper J.N., Charnock-Jones D.S., Burton G.J. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002, 90:1274-1281.
46. Huppertz B., Frank H.G., Kingdom J.C., Reister F., Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998, 110:495-508.
47. Redman C.W., Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000, 21:597-602.
48. Redman C.W., Sargent I.L. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001, 29:518-522.
49. Huppertz B., Kingdom J., Caniggia L., Desoye G., Black S., Korr H., et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003, 24:181-190.
50. Chua S., Wilkins T., Sargent I., Redman C. Trophoblast deportation in pre-eclamptic pregnancy. BrJ Obstet Gynaecol 1991, 98:973-979.
51. Smarason A.K., Sargent I.L., Starkey P.M., Redman C.W. The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993, 100:943-944.
52. Zhong X.Y., Laivuori H., Livingston J.C., Ylikorkala O., Sibai B.M., Holzgreve W., et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001, 184:414-419.
53. Knight M., Redman C.W., Linton E.A., Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998, 105:632-640.
54. Cockell A.P., Learmont J.G., Smarason A.K., Redman C.W., Sargent I.L., Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 1997, 104:235-240.
55. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998, 179:1359-1375.
56. Conrad K.P., Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997, 37:240-249.
57. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
58. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649.
59. Hung T.H., Charnock-Jones D.S., Skepper J.N., Burton G.J. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004, 164:1049-1061.
60. Hung T.H., Skepper J.N., Burton G.J. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001, 159:1031-1043.
61. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998, 16:5-15.
62. Khalil R.A., Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002, 283:R29-45.
63. Gaber L.W., Spargo B.H., Lindheimer M.D. Renal pathology in pre-eclampsia. Baillieres Clin Obstet Gynaecol 1994, 8:443-468.
64. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003, 111:707-716.
65. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
66. Luttun A., Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?. J Clin Invest 2003, 111:600-602.
67. Tsatsaris V., Goffin F., Munaut C., Brichant J.F., Pignon M.R., Noel A., et al. Over expression of the soluble vascular endothelial growth factor receptor (sVEGFR-1) in preeclamptic patients: pathophysiological consequences. J Clin EndocMetab 2003, 88:5555-5563.
68. Gougos A., St Jacques S., Greaves A., O'Connell P.J., d'Apice A.J., Bühring H.J., et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992, 4:83-92.
69. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.